Back
Fulcrum Therapeutics, Inc. Stock Price Chart
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
50
FULC
Fulcrum Therapeutics, Inc.
Last Price:
$12.30
Seasonality Move:
0.09%
7 Day Trial
ALL ACCESS PASS
$
7
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
The current trend is moderately bullish and FULC is experiencing selling pressure, which indicates risk of future bearish movement.
Fulcrum Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.09 | Sell |
| 20-day SMA: | 11.48 | Buy |
| 50-day SMA: | 9.95 | Buy |
| 200-day SMA: | 6.98 | Buy |
| 8-day EMA: | 12.35 | Sell |
| 20-day EMA: | 11.48 | Buy |
| 50-day EMA: | 10.22 | Buy |
| 200-day EMA: | 7.79 | Buy |
Fulcrum Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.9 | Buy |
| Relative Strength Index (14 RSI): | 55.83 | Buy |
| Chaikin Money Flow: | -624738 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.2 - 12.78) | Buy |
| Bollinger Bands (100): | (6.73 - 10.53) | Buy |
Fulcrum Therapeutics, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Fulcrum Therapeutics, Inc. Stock
Is Fulcrum Therapeutics, Inc. Stock a Buy?
-
Fulcrum Therapeutics, Inc. share price is 12.08 while FULC 8-day simple moving average is 13.09, which is a Sell signal.
-
The stock price of FULC is 12.08 while Fulcrum Therapeutics, Inc. 20-day SMA is 11.48, which makes it a Buy.
-
Fulcrum Therapeutics, Inc. 50-day simple moving average is 9.95 while FULC share price is 12.08, making it a Buy technically.
-
FULC stock price is 12.08 and Fulcrum Therapeutics, Inc. 200-day simple moving average is 6.98, creating a Buy signal.
FULC Technical Analysis vs Fundamental Analysis
Sell
50
Fulcrum Therapeutics, Inc. (FULC)
is a Sell
Is Fulcrum Therapeutics, Inc. a Buy or a Sell?
-
Fulcrum Therapeutics, Inc. stock is rated a SellThe current Fulcrum Therapeutics, Inc. [FULC] share price is $12.08. The Score for FULC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Fulcrum Therapeutics, Inc. Stock Info
Market Cap:
653.8M
Price in USD:
12.08
Share Volume:
768.9K
Fulcrum Therapeutics, Inc. 52-Week Range
52-Week High:
15.74
52-Week Low:
2.32
Sell
50
Fulcrum Therapeutics, Inc. (FULC)
is a Sell
Fulcrum Therapeutics, Inc. Share Price Forecast
-
What is the Fulcrum Therapeutics, Inc. stock price today?The Fulcrum Therapeutics, Inc. stock price is 12.08 USD today.
-
Will FULC stock go up or go down?Fulcrum Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Fulcrum Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Fulcrum Therapeutics, Inc. is overvalued.
Is Fulcrum Therapeutics, Inc. Stock a Buy?
-
Fulcrum Therapeutics, Inc. share price is 12.08 while FULC 8-day exponential moving average is 12.35, which is a Sell signal.
-
The stock price of FULC is 12.08 while Fulcrum Therapeutics, Inc. 20-day EMA is 11.48, which makes it a Buy.
-
Fulcrum Therapeutics, Inc. 50-day exponential moving average is 10.22 while FULC share price is 12.08, making it a Buy technically.
-
FULC stock price is 12.08 and Fulcrum Therapeutics, Inc. 200-day simple moving average is 7.79, creating a Buy signal.
Fundamental Analysis of Fulcrum Therapeutics, Inc.
Is Fulcrum Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.03 per share, and a decrease next year of $0.03 per share.
Technical Analysis of Fulcrum Therapeutics, Inc.
Should I short Fulcrum Therapeutics, Inc. stock?
-
FULC Moving Average Covergence Divergence (MACD) indicator is 0.9, suggesting Fulcrum Therapeutics, Inc. is a Buy
-
Fulcrum Therapeutics, Inc. Relative Strength Index (RSI) is 55.83, which suggest Fulcrum Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Fulcrum Therapeutics, Inc. is (9.2 - 12.78), which suggest Fulcrum Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Fulcrum Therapeutics, Inc. is (6.73 - 10.53), which suggest Fulcrum Therapeutics, Inc. is a Buy
* Fulcrum Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.